Michael Griffin
Stock Analyst at Citigroup
(2.92)
# 1,581
Out of 4,960 analysts
15
Total ratings
100%
Success rate
25.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Michael Griffin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JLL Jones Lang LaSalle | Maintains: Neutral | $275 → $240 | $303.19 | -20.84% | 5 | May 28, 2025 | |
| CBRE CBRE Group | Maintains: Buy | $130 → $160 | $164.41 | -2.68% | 5 | Nov 25, 2024 | |
| AHR American Healthcare REIT | Initiates: Neutral | $14 | $42.47 | -67.04% | 1 | Mar 4, 2024 | |
| HR Healthcare Realty Trust | Maintains: Neutral | $19 → $17 | $16.97 | +0.18% | 2 | Aug 22, 2023 | |
| HPP Hudson Pacific Properties | Maintains: Neutral | $5 → $4.5 | $2.69 | +67.29% | 2 | May 19, 2023 |
Jones Lang LaSalle
May 28, 2025
Maintains: Neutral
Price Target: $275 → $240
Current: $303.19
Upside: -20.84%
CBRE Group
Nov 25, 2024
Maintains: Buy
Price Target: $130 → $160
Current: $164.41
Upside: -2.68%
American Healthcare REIT
Mar 4, 2024
Initiates: Neutral
Price Target: $14
Current: $42.47
Upside: -67.04%
Healthcare Realty Trust
Aug 22, 2023
Maintains: Neutral
Price Target: $19 → $17
Current: $16.97
Upside: +0.18%
Hudson Pacific Properties
May 19, 2023
Maintains: Neutral
Price Target: $5 → $4.5
Current: $2.69
Upside: +67.29%